Both the RT-PCR and western blot results indicate that HIF1α is oncogenic and upregulated when the Redox and Krebs oncometabolites are also highly expressed in CML; on the other hand, Notch1 behaves like a tumor suppressor in CML cases. The gene discussed is HIF1A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.